Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a ‘Case Study’
出版年份 2015 全文链接
标题
Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a ‘Case Study’
作者
关键词
Bladder cancer, Dapagliflozin, Hematuria, SGLT2 inhibitor, Type 2 diabetes mellitus
出版物
Diabetes Therapy
Volume 6, Issue 3, Pages 357-375
出版商
Springer Nature
发表日期
2015-08-31
DOI
10.1007/s13300-015-0128-9
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Sex-, Species-, and Tissue-Specific Metabolism of Empagliflozin in Male Mouse Kidney Forms an Unstable Hemiacetal Metabolite (M466/2) That Degrades to 4-Hydroxycrotonaldehyde, a Reactive and Cytotoxic Species
- (2015) Mitchell E. Taub et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Evaluating Hematuria: Impact of Guideline Adherence on Urologic Cancer Diagnosis
- (2014) Atul B. Shinagare et al. AMERICAN JOURNAL OF MEDICINE
- Variation in the Intensity of Hematuria Evaluation: A Target for Primary Care Quality Improvement
- (2014) David F. Friedlander et al. AMERICAN JOURNAL OF MEDICINE
- Recurrent urinary tract infection and risk of bladder cancer in the Nijmegen bladder cancer study
- (2014) S H Vermeulen et al. BRITISH JOURNAL OF CANCER
- Carcinogenicity in rats of the SGLT2 inhibitor canagliflozin
- (2014) Sandra De Jonghe et al. CHEMICO-BIOLOGICAL INTERACTIONS
- The glucagon-like peptide-1-based therapeutics exenatide and saxagliptin did not cause detrimental effects on the pancreas in mice, rats, dogs and monkeys
- (2014) D. Roy et al. DIABETES OBESITY & METABOLISM
- Glucagon-like peptide-1 receptor agonists and pancreatitis: A meta-analysis of randomized clinical trials
- (2014) Matteo Monami et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Dapagliflozin Added to Usual Care in Individuals with Type 2 Diabetes Mellitus with Preexisting Cardiovascular Disease: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study with a 28-Week Extension
- (2014) Lawrence A. Leiter et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening progression
- (2014) Hiroaki Kobayashi et al. BMC Urology
- Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies
- (2014) L. Li et al. BMJ-British Medical Journal
- Carcinogenicity Risk Assessment Supports the Chronic Safety of Dapagliflozin, an Inhibitor of Sodium–Glucose Co-Transporter 2, in the Treatment of Type 2 Diabetes Mellitus
- (2014) Timothy P. Reilly et al. Diabetes Therapy
- Long-Term Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Receiving High Doses of Insulin
- (2013) John P.H. Wilding ANNALS OF INTERNAL MEDICINE
- Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies
- (2013) Zhaowei Zhu et al. BMC CANCER
- Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
- (2013) Clifford J Bailey et al. BMC Medicine
- Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial
- (2013) Markolf Hanefeld et al. Current Diabetes Reports
- Diabetes Mellitus Increases the Risk of Bladder Cancer: An Updated Meta-Analysis of Observational Studies
- (2013) Hong Fang et al. Diabetes Technology & Therapeutics
- Inhibition of Renal Glucose Reabsorption: A Novel Strategy for Achieving Glucose Control in Type 2 Diabetes Mellitus
- (2013) Muhammad Abdul-Ghani et al. Endocrine Practice
- Nonclinical Toxicology Assessments Support the Chronic Safety of Dapagliflozin, a First-in-Class Sodium-Glucose Cotransporter 2 Inhibitor
- (2013) Mark Tirmenstein et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Peroxisome Proliferator-Activated Receptor Agonists and Bladder Cancer: Lessons from Animal Studies
- (2013) CHIN-HSIAO TSENG et al. JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS
- Pioglitazone and bladder cancer: a propensity score matched cohort study
- (2012) Li Wei et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical features of bladder cancer in primary care
- (2012) Elizabeth A Shephard et al. BRITISH JOURNAL OF GENERAL PRACTICE
- Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
- (2012) Muhammad A. Abdul-Ghani et al. Current Diabetes Reports
- Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy
- (2012) J. Rosenstock et al. DIABETES CARE
- Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial
- (2012) K. Kaku et al. DIABETES OBESITY & METABOLISM
- A meta-analysis of serious adverse events reported with exenatide and liraglutide: Acute pancreatitis and cancer
- (2012) Carlos Alves et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Type 2 diabetes mellitus, insulin-use and risk of bladder cancer in a large cohort study
- (2012) Christina C. Newton et al. INTERNATIONAL JOURNAL OF CANCER
- Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone: Interim report of a longitudinal cohort study
- (2011) J. D. Lewis et al. DIABETES CARE
- Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin: A randomized, 52-week, double-blind, active-controlled noninferiority trial
- (2011) M. A. Nauck et al. DIABETES CARE
- Long-term effects of insulin glargine on the risk of breast cancer
- (2011) S. Suissa et al. DIABETOLOGIA
- Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study
- (2011) R. Ruiter et al. DIABETOLOGIA
- Diabetes and risk of bladder cancer
- (2010) Todd MacKenzie et al. CANCER
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- SMOKING AND UROLOGICAL DISEASE
- (2009) Paul Crow et al. BJU INTERNATIONAL
- Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
- (2009) L. G. Hemkens et al. DIABETOLOGIA
- A Case–Control Study of Smoking and Bladder Cancer Risk: Emergent Patterns Over Time
- (2009) Dalsu Baris et al. JNCI-Journal of the National Cancer Institute
- Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction
- (2008) L. Tian et al. BIOSTATISTICS
- Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
- (2008) J. F. List et al. DIABETES CARE
- Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey
- (2008) Alan M. Nieder et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Patterns of Hematuria Referral to Urologists: Does a Gender Disparity Exist?
- (2008) Emilie K. Johnson et al. UROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now